Table 1 Patient demographics

Age (years)

Median

69

Range

52–83

Gleason†

6–7

33 (61.1 %)

8–9

20 (37.0 %)

Initial PSA

Median

9.15

Range

1.3–36.0

Pre-PSMA PSA

Median

1.1

Range

0.017–20.4

Reason for PET n (%)

Pre-radical IMRT staging

8 (14.8 %)

Pre-PPRT staging

18 (33.3 %)

PSA failure after IMRT

9 (16.7 %)

PSA failure after PPRT

18 (33.3 %)

Response to systemic therapy

1 (1.9 %)